Penumbra expands CAVT for stroke into Europe with Thunderbolt CE mark

Penumbra announced today that it has secured a CE mark in Europe for Thunderbolt, which the company says further lays the groundwork for computer-assisted vacuum thrombectomy (CAVT) technology being launched to address acute ischaemic stroke globally. Penumbra also received US Food and Drug Administration (FDA) clearance for Thunderbolt last week. “Stroke is the second-leading cause […]Read More